FDA approved a new inhaler drug for chronic COPD - Zeepharmacy.co
Register with us in one easy step!
Add your Naples Florida Press Release or Company Profile to NAPLESPLUS
Press Release Give your opinion about this listing via "Review" or suggest corrections/additions
Add your Naples Florida Press Release or Company Profile to NAPLESPLUS
Press Release Give your opinion about this listing via "Review" or suggest corrections/additions
The FDA announced the approval of a form of new long-term treatment for patients suffering from chronic obstructive pulmonary disease (COPD).
20 July 2013, USA (http://www.zeepharmacy.co): The FDA announced the approval of a form of new long-term treatment for patients suffering from chronic obstructive pulmonary disease (COPD). The new treatment is an inhaler drug called Breo Ellipta (fluticasone furoate and vilanterol inhalation powder). It is also sanctioned for the treatment of exacerbations in COPD patients.
COPD is a form of lung disease that progressively gets worse; it is characterized by the occurrence of chronic bronchitis or emphysema (a pair of co-existing diseases that narrow the airways). Symptoms include chest tightness, shortness of breath, excessive phlegm and chronic cough. COPD is one of the major causes of death worldwide.
Current and former long-term smokers are at the highest risk of developing COPD. The management tactics of the disease include: quitting smoking (among smokers), vaccination and drug therapies (usually involving the use of inhalers). The new inhaler, works by reducing inflammation in the lungs as well as relaxing the muscles around the airways, and this results in the improvement of airflow and prevents wheezing and breathlessness.
Breo Ellipta is a combination of two different drugs: and vilanterol, a long-acting beta2-adrenergic agonist (LABA), fluticasone furoate, an inhaled corticosteroid. The results of the study indicated that, Breo Ellipta was very effective at improving lung function and reducing exacerbations.
Breo Ellipta is not approved for the treatment of asthma. In addition, the medication is not recommended for people under the age of 18 and should not be used as a rescue therapy to treat sudden breathing complications.
Side effects linked to Breo Ellipta therapy are: • Increased risk of pneumonia • Bone fractures • Headache • Inflammation of the nasal passage • Thrush • Upper respiratory tract infection
ZeePharmacy 1600 Pennsylvania Ave, Washington, DC, USA, 20002. 011-6654789986 For more please visit our site Label
Camili Smith is a Medical Student and a freelancer who is specialized in writing. He is associated with many Pharmacies for whom he writes news based on generic drugs like Generic Viagra, generic amoxicillin.
Rate this! 1-5 starsCOPD is a form of lung disease that progressively gets worse; it is characterized by the occurrence of chronic bronchitis or emphysema (a pair of co-existing diseases that narrow the airways). Symptoms include chest tightness, shortness of breath, excessive phlegm and chronic cough. COPD is one of the major causes of death worldwide.
Current and former long-term smokers are at the highest risk of developing COPD. The management tactics of the disease include: quitting smoking (among smokers), vaccination and drug therapies (usually involving the use of inhalers). The new inhaler, works by reducing inflammation in the lungs as well as relaxing the muscles around the airways, and this results in the improvement of airflow and prevents wheezing and breathlessness.
Breo Ellipta is a combination of two different drugs: and vilanterol, a long-acting beta2-adrenergic agonist (LABA), fluticasone furoate, an inhaled corticosteroid. The results of the study indicated that, Breo Ellipta was very effective at improving lung function and reducing exacerbations.
Breo Ellipta is not approved for the treatment of asthma. In addition, the medication is not recommended for people under the age of 18 and should not be used as a rescue therapy to treat sudden breathing complications.
Side effects linked to Breo Ellipta therapy are: • Increased risk of pneumonia • Bone fractures • Headache • Inflammation of the nasal passage • Thrush • Upper respiratory tract infection
ZeePharmacy 1600 Pennsylvania Ave, Washington, DC, USA, 20002. 011-6654789986 For more please visit our site Label
Camili Smith is a Medical Student and a freelancer who is specialized in writing. He is associated with many Pharmacies for whom he writes news based on generic drugs like Generic Viagra, generic amoxicillin.
Comments
Add a reviewNOTE: If your business information is incorrect, or you want ownership of your page (free), please see How do I modify my NAPLESPLUS business listing or find out more about this business?
